A Case Study on Pharmaceutical Sector: Indian Context

Abstract

The Indian pharmaceutical sector has recorded a remarkable growth with tremendous scope of service offering and employment. The sector ranks as the third-largest pharmaceutical market globally by volume and 14th by value, playing a critical role in making healthcare accessible worldwide. With over 10,000 manufacturing units and more than 3,000 pharmaceutical companies, India is a major exporter of medicines, supplying over 200 countries, including highly regulated markets like the United States and the European Union. Additionally, India’s adherence to stringent global standards, such as those set by the U.S. Food and Drug Administration (FDA) and the World Health Organization’s Good Manufacturing Practices (WHO-GMP), has cemented its reputation as a reliable supplier of safe and effective pharmaceuticals. (www.ibef.org, 2024)

The Indian pharmaceutical firms have consistently prioritized quality, resulting in the production of affordable yet reliable medicines. India’s pharmaceutical sector is also experiencing a digital transformation, integrating cutting-edge technologies to enhance efficiency and patient care. This case study explores the Indian pharmaceutical sector, focusing on its current status, associated dilemmas, and strategies to address them. It provides insights into the dynamics of the industry within the Indian context, offering a practical understanding for students, business owners, and executives in the pharmaceutical sector. The case literature also contributes Teaching Notes at the end of the case for the case Instructors referring the case.